Seeing Is Believing

Currently out of the existing stock ratings of Richard Newitter, 306 are a BUY (57.3%), 226 are a HOLD (42.32%), 2 are a SELL (0.37%).
Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 66.74% that have a potential upside of 22.18% achieved within 197 days.
Richard Newitter’s has documented 1,062 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EW, Edwards Lifesciences Corp at 28-Oct-2025.
Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 4/21/2021. The price target of $286.67 was fulfilled within 1 day with a profit of $10.46 (3.52%) receiving and performance score of 35.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$91
$17.11 (23.16%)
$106
21 days ago
(13-Oct-2025)
8/11 (72.73%)
$18.4 (25.34%)
110
Hold
$86
$12.11 (16.39%)
$96
21 days ago
(13-Oct-2025)
5/6 (83.33%)
$13.4 (18.46%)
691
Buy
$85
$11.11 (15.04%)
$100
1 months 5 days ago
(29-Sep-2025)
4/5 (80%)
$10.89 (14.69%)
119
Hold
$77.53
$3.64 (4.93%)
$85.88
2 months 13 days ago
(21-Aug-2025)
2/2 (100%)
$-1.65 (-2.08%)
111
Buy
$110
$36.11 (48.87%)
$120
2 months 13 days ago
(21-Aug-2025)
8/11 (72.73%)
$30.82 (38.92%)
338
Which stock is Richard Newitter is most bullish on?
Which stock is Richard Newitter is most reserved on?
What Year was the first public recommendation made by Richard Newitter?